Kidney Transplant Patients
Conditions
Keywords
Neuro Linguistic Programming, fear of covid-19, kidney transplant patients, nurse
Brief summary
The study was conducted experimentally to evaluate the effect of neurolinguistic programming on COVID-19 fear in kidney transplant patients.
Detailed description
The study was conducted experimentally (prospective randomized single-blind clinical trial model) to evaluate the effect of neurolinguistic programming (NLP) on fear of Covid-19 in kidney transplant patients. The study was carried out between June 2021 and October 2021. Personal Information Form and Fear of COVID-19 Scale (FCV-19S) were used to collect data. The data obtained from the research were evaluated with SPSS 25. According to the calculation made using G\*power 3.1 software, the sample size was determined as 74 (each group 37) with an effect size of 0.80, a margin of error of 0co.05, a confidence level of 0.95, and a population representation of 0.95. Simple random sampling method, one of the probability sampling methods, was used to determine the participants. Single-group columns between 1 and 300 were created using the Random Integer Generator method, which located in the Numbers sub-heading of the random.org website for the participants who met the sample selection criteria. Participants were randomly assigned to numbers 1 and 2, considering the numbers 1 and 2 in the column. The number of the experimental or control group was determined by drawing lots at the beginning of the research
Interventions
Sub modality Technique: People experience the world with their five senses, and the thoughts that an individual creates in his brain about a situation are coded with these five senses. When these encodings change, the individual's perception of the situation will also change
Sponsors
Study design
Masking description
Participants did not know they were in the experimental or control group.
Intervention model description
The population of the study consisted of patients who had kidney transplants in the hospital in question. The sample of the study was determined by power analysis. According to the calculation made using G\*power 3.1 software, the sample size was determined as 74 (each group 37) with an effect size of 0.80, a margin of error of 0co.05, a confidence level of 0.95, and a population representation of 0.95. Simple random sampling method, one of the probability sampling methods, was used to determine the participants. Single-group columns between 1 and 300 were created using the Random Integer Generator method, which located in the Numbers sub-heading of the random.org website for the participants who met the sample selection criteria. Participants were randomly assigned to numbers 1 and 2, considering the numbers 1 and 2 in the column. The number of the experimental or control group was determined by drawing lots at the beginning of the research.
Eligibility
Inclusion criteria
Patients who could communicate verbally, had no hearing problems, had a high or moderate fear of Covid-19 (20 or more), and had not applied NLP before were included in the study. \-
Exclusion criteria
Patients who wanted to leave voluntarily at any stage after being included in the study, and who had to be hospitalized again for organ rejection or any other reason while the study was ongoing, were excluded from the study. \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| A mean total score on the | Fear of COVID-19 Scale . After applying the personal information form and Fear of COVID-19 Scale (FCV-19S) to the patients in the experimental group, the sub-modality technique of NLP was applied once, and then FCV-19S was applied again one week later | Fear of COVID-19 Scale (FCV-19S) |
Countries
Turkey (Türkiye)